Novo Nordisk A/S
เพิ่มขึ้น

Correction Over?

Head and Shoulders pattern complete, we are 32% down from all time high.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.

The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.

Not financial advise, do what's best for you.
Chart PatternsWave Analysis

คำจำกัดสิทธิ์ความรับผิดชอบ